News
Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...
As a new variant that causes 'razor blade throat' spreads, the FDA updates vaccine warnings to include information on heart ...
15h
GlobalData on MSNModerna’s mRNA flu shot outperforms current standard at Phase IIIThe trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.
Labels for the Pfizer and Moderna shots, which already caution about myocarditis and pericarditis, will more strongly stress ...
Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose ...
The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.
The US Food and Drug Administration (FDA) has required and approved updates to the Prescribing Information for Comirnaty ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...
The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results